"Basal Ganglia Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
Descriptor ID |
D001480
|
MeSH Number(s) |
C10.228.140.079
|
Concept/Terms |
Basal Ganglia Diseases- Basal Ganglia Diseases
- Basal Ganglia Disease
- Basal Ganglia Disorders
- Basal Ganglia Disorder
|
Below are MeSH descriptors whose meaning is more general than "Basal Ganglia Diseases".
Below are MeSH descriptors whose meaning is more specific than "Basal Ganglia Diseases".
This graph shows the total number of publications written about "Basal Ganglia Diseases" by people in this website by year, and whether "Basal Ganglia Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2017 | 1 | 2 | 3 |
2018 | 1 | 0 | 1 |
2019 | 2 | 0 | 2 |
2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Basal Ganglia Diseases" by people in Profiles.
-
COVID-19 Unveiling Brain Calcifications. J Mol Neurosci. 2022 Jan; 72(1):25-26.
-
Fahr's syndrome presenting with seizures in SARS-CoV-2 (COVID-19) pneumonia-a case report. Neurol Sci. 2020 Nov; 41(11):3063-3065.
-
Dolutegravir-induced extrapyramidal syndrome in a young woman. AIDS. 2019 03 15; 33(4):763-764.
-
Psychopathology and extrapyramidal side effects in smoking and non-smoking patients with schizophrenia: Systematic review and meta-analysis of comparative studies. Prog Neuropsychopharmacol Biol Psychiatry. 2019 06 08; 92:476-482.
-
Using an Integrated Care Pathway for Late-Life Schizophrenia Improves Monitoring of Adverse Effects of Antipsychotics and Reduces Antipsychotic Polypharmacy. Am J Geriatr Psychiatry. 2019 01; 27(1):84-90.
-
[Magnetic resonance imaging features of Cryptococcus infection in central nervous system in patients with AIDS]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Oct 28; 42(10):1184-1190.
-
Musculoskeletal Disease in MDA5-Related Type I Interferonopathy: A Mendelian Mimic of Jaccoud's Arthropathy. Arthritis Rheumatol. 2017 10; 69(10):2081-2091.
-
Anticholinergic use trends in 14,013 patients with schizophrenia from three national surveys on the use of psychotropic medications in China (2002-2012). Psychiatry Res. 2017 11; 257:132-136.
-
GBA-associated parkinsonism and dementia: beyond a-synucleinopathies? Eur J Neurol. 2016 Mar; 23(3):520-6.
-
Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. Arch Gerontol Geriatr. 2008 Jul-Aug; 47(1):53-61.